Aspira Women’s Health (AWH) has released an update to notify the public and investors about an entry into a material definitive agreement.
Aspira Women’s Health Inc. entered into agreements with A.G.P./Alliance Global Partners and various purchasers for a securities offering involving the sale of 1,371,000 shares of common stock and warrants to purchase additional shares. The offering, expected to close on January 26, 2024, anticipates generating approximately $5.5 million before fees and expenses, with shares and warrants priced according to the closing bid price on The Nasdaq Capital Market. The agreements also include customary representations, warranties, closing conditions, and indemnification obligations, as well as an amendment to previously issued warrants to reduce their exercise price and extend their termination date.
For further insights into AWH stock, check out TipRanks’ Stock Analysis page.
